Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions.

Tardif JC, Grégoire J, L'Allier PL, Anderson TJ, Bertrand O, Reeves F, Title LM, Alfonso F, Schampaert E, Hassan A, McLain R, Pressler ML, Ibrahim R, Lespérance J, Blue J, Heinonen T, Rodés-Cabau J; Avasimibe and Progression of Lesions on UltraSound (A-PLUS) Investigators..

Circulation. 2004 Nov 23;110(21):3372-7. Epub 2004 Nov 8.

2.

Inhibitors of acyl-coenzyme a: cholesterol acyltransferase.

Miyazaki A, Kanome T, Watanabe T.

Curr Drug Targets Cardiovasc Haematol Disord. 2005 Dec;5(6):463-9. Review.

PMID:
16503866
3.

Pharmacology of the ACAT inhibitor avasimibe (CI-1011).

Llaverías G, Laguna JC, Alegret M.

Cardiovasc Drug Rev. 2003 Spring;21(1):33-50. Review.

PMID:
12595916
4.

Therapies on the horizon for cholesterol reduction.

Brown WV.

Clin Cardiol. 2001 Aug;24(8 Suppl):III24-7. Review.

5.

Avasimibe Pfizer.

Burnett JR, Huff MW.

Curr Opin Investig Drugs. 2002 Sep;3(9):1328-33. Review.

PMID:
12498009
6.

[Acyl-coenzyme A: cholesterol acyltransferase (ACAT)].

Miyazaki A, Watanabe T.

Nihon Rinsho. 2004 Dec;62 Suppl 12:89-91. Review. Japanese. No abstract available.

PMID:
15658270
7.

Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound.

Gao WQ, Feng QZ, Li YF, Li YX, Huang Y, Chen YM, Yang B, Lu CY.

BMC Cardiovasc Disord. 2014 May 2;14:60. doi: 10.1186/1471-2261-14-60. Review.

9.

Pitavastatin: novel effects on lipid parameters.

Chapman MJ.

Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Review.

PMID:
22152282
10.

New advances in lipid-modifying therapies for reducing cardiovascular risk.

Bruckert E.

Cardiology. 2002;97(2):59-66. Review.

PMID:
11978950
11.

Intravascular ultrasound for the evaluation of therapies targeting coronary atherosclerosis.

Böse D, von Birgelen C, Erbel R.

J Am Coll Cardiol. 2007 Mar 6;49(9):925-32. Epub 2007 Feb 16. Review.

12.

Association between LDL-C, Non HDL-C, and Apolipoprotein B Levels with Coronary Plaque Regression.

Masson W, Siniawski D, Lobo M, Molinero G, Giorgi M, Huerín M.

Arq Bras Cardiol. 2015 Jul;105(1):11-9. doi: 10.5935/abc.20150050. Epub 2015 May 19. Review. English, Portuguese.

13.

Studying coronary plaque regression with IVUS: a critical review of recent studies.

Carlier SG, Tanaka K.

J Interv Cardiol. 2006 Feb;19(1):11-5. Review. No abstract available.

PMID:
16483334

Supplemental Content

Support Center